Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06122103 · ClinicalTrials.gov registry record
Comparison of Visual Outcomes With Mini-Monovision Between a Monofocal and an Adjustable Intraocular Lens
A clinical trial, sponsored by Gainesville Eye Associates.
- Completed
- Registry status
- 138
- Enrollment target
NCT06122103: Completed study, sponsored by Gainesville Eye Associates.
NCT06122103 is a clinical trial that has completed, run by Gainesville Eye Associates. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06122103 has completed, sponsored by Gainesville Eye Associates.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
This study is a single center, multi-surgeon, prospective, randomized, comparative study of binocular corrected distance visual acuity (CDVA) after successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively and at up to 6 postoperative visits. Clinical evaluations will include administration of patient reported spectacle usage questionnaire (PRSIQ), as well as measurement of monocular and binocular visual acuities at distance, intermediate, and near, defocus curve, manifest refraction, measurement of higher order aberrations.
Interventions
- DEVICE Clareon Monofocal
- DEVICE Light-Adjustable Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2025-02-10 |
What the finished NCT06122103 record still lists
NCT06122103 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Clareon Monofocal is the first listed.
NCT06122103 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06122103 about?
NCT06122103 is a clinical study titled "Comparison of Visual Outcomes With Mini-Monovision Between a Monofocal and an Adjustable Intraocular Lens". This study is a single center, multi-surgeon, prospective, randomized, comparative study of binocular corrected distance visual acuity (CDVA) after successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively and at up to 6 postoperative visits. Clinical evaluations ...
What is the current status of trial NCT06122103?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2023-11-21. Estimated completion is 2025-02-10.
What interventions are being tested in trial NCT06122103?
The interventions under investigation include: Clareon Monofocal (DEVICE), Light-Adjustable Lens (DEVICE).
Who is sponsoring clinical trial NCT06122103?
This trial is sponsored by Gainesville Eye Associates, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI